Improving intraperitoneal chemotherapeutic effect and preventing postsurgical adhesions simultaneously with biodegradable micelles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 963-973

  Gong, ChangYang ^a   Yang, Bing ^b   Qian, ZhiYong ^a   Zhao, Xia ^b   Wu, QinJie ^a   Qi, XiaoRong ^b   Wang, YuJun ^a   Guo, Gang ^a   Kan, Bing ^a   Luo, Feng ^a   Wei, YuQuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Antiadhesion barrier; Drug delivery system; Intraperitoneal chemotherapy; Micelles; Postsurgical adhesion

Indexed keywords

ABDOMINAL TUMORS; ANTIADHESION; BARRIER METHOD; BIODEGRADABLE MICELLES; BODY TEMPERATURE; CANCER CELLS; CLINICAL USE; CONTROLLED DRUG DELIVERY SYSTEMS; CYTOREDUCTIVE SURGERY; DISTANT FUTURES; DRUG DELIVERY SYSTEM; INTRAPERITONEAL; MICELLAR AGGREGATION; MOUSE MODELS; NOVEL STRATEGIES; POLY(E-CAPROLACTONE); POSTSURGICAL ADHESION; RESIDUAL TUMORS;

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DIAGNOSIS; MICELLES; POLYETHYLENE GLYCOLS; SURGERY; TUMORS;

ADHESION;

COPOLYMER; DOXORUBICIN; MACROGOL; POLY(ETHYLENE GLYCOL) POLY(EPSILON CAPROLACTONE) POLY(ETHYLENE GLYCOL) COPOLYMER; POLYCAPROLACTONE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABLE IMPLANT; BODY TEMPERATURE; CELL AGGREGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; MICELLE; MOUSE; NONHUMAN; PERITONEUM ADHESION; THERAPY EFFECT; TISSUE ADHESION;

ABSORBABLE IMPLANTS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG SYNERGISM; FEMALE; MICE; MICE, INBRED BALB C; MICELLES; NANOCAPSULES; PERITONEAL NEOPLASMS; TISSUE ADHESIONS; TREATMENT OUTCOME;

EID: 84864083003     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.10.010     Document Type: Article

References (49)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer Statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Ozols R.F., Bookman M.A., Young R.C. Intraperitoneal chemotherapy for ovarian cancer. N Engl J Med 2006, 354:1641-1643.
3. Elias D., Blot F., El Otmany A., Antoun S., Lasser P., Boige V., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001, 92:71-76.
4. Portilla A.G., Sugarbaker P.H., Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg 1999, 23:23-29.
5. Sugarbaker P.H., Jablonski K.A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995, 221:124.
6. Armstrong D., Bundy B., Wenzel L., Huang H., Baergen R., Lele S., et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006, 354:34-43.
7. Petignat P., du Bois A., Bruchim I., Fink D., Provencher D.M. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?. Crit Rev Oncol Hematol 2007, 62:137-147.
8. Kehoe S.M., Williams N.L., Yakubu R., Levine D.A., Chi D.S., Sabbatini P.J., et al. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies. Gynecol Oncol 2009, 113:228-232.
9. Culliford A.T., Brooks A.D., Sharma S., Saltz L.B., Schwartz G.K., O'Reilly E.M., et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 2001, 8:787-795.
10. Esquivel J., Sticca R., Sugarbaker P., Levine E., Yan T., Alexander R., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 2007, 14:128-133.
11. Glehen O., Kwiatkowski F., Sugarbaker P., Elias D., Levine E., De Simone M., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004, 22:3284.
12. Pestieau S.R., Sugarbaker P.H. Treatment of primary colon cancer with peritoneal carcinomatosis. Dis Colon Rectum 2000, 43:1341-1346.
13. Verwaal V.J., Bruin S., Boot H., van Slooten G., van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008, 15:2426-2432.
14. Verwaal V.J., van Ruth S., de Bree E., van Slooten G.W., van Tinteren H., Boot H., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003, 21:3737.
15. Weibel M.A., Majno G. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg 1973, 126:345-353.
16. Menzies D., Ellis H. Intestinal obstruction from adhesions-how big is the problem?. Ann R Coll Surg Engl 1990, 72:60-63.
17. Postoperative adhesion development after operative laparoscopy: evaluation at early second-look procedures. Operative Laparoscopy Study Group. Fertil Steril 1991, 55:700-704. Group OLS.
18. DeCherney A.H., diZerega G.S. Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 1997, 77:671-688.
19. Ray N.F., Denton W.G., Thamer M., Henderson S.C., Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998, 186:1-9.
20. Coleman M.G., McLain A.D., Moran B.J. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colon Rectum 2000, 43:1297-1299.
21. Parker M.C., Ellis H., Moran B.J., Thompson J.N., Wilson M.S., Menzies D., et al. Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery. Dis Colon Rectum 2001, 44:822-829.
22. Fazio V.W., Cohen Z., Fleshman J.W., van Goor H., Bauer J.J., Wolff B.G., et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 2006, 49:1-11.
23. Gong C.Y., Shi S., Dong P.W., Zheng X.L., Fu S.Z., Guo G., et al. In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(e-caprolactone)-poly(ethylene glycol) copolymer. BMC Biotech 2009, 9:8.
24. Gong C.Y., Shi S., Dong P.W., Kan B., Gou M.L., Wang X.H., et al. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm 2009, 365:89-99.
25. Gong C.Y., Dong P.W., Shi S., Fu S.Z., Yang J.L., Guo G., et al. Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study. J Pharm Sci 2009, 98:3707-3717.
26. Gong C.Y., Shi S., Wang X.H., Wang Y.J., Fu S.Z., Dong P.W., et al. Novel composite drug delivdery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(e-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(e-caprolactone)-poly(ethylene glycol) hydrogel. J Phys Chem B 2009, 113:10183-10188.
27. Gong C.Y., Wu Q.J., Dong P.W., Shi S., Fu S.Z., Guo G., et al. Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel. J Biomed Mater Res 2009, 91B:26-36.
28. Gong C.Y., Qian Z.Y., Liu C.B., Huang M.J., Gu Y.C., Wen Y.J., et al. A thermosensitive hydrogel based on biodegradable amphiphilic poly(ethylene glycol)-polycaprolactone-poly(ethylene glycol) block copolymers. Smart Mater Struct 2007, 16:927-933.
29. Kennedy R., Costain D., McAlister V., Lee T. Prevention of experimental postoperative peritoneal adhesions by N, O-carboxymethyl chitosan*. Surgery 1996, 120:866-870.
30. Kosaka H., Yoshimoto T., Fujimoto J., Nakanishi K. Interferon-γ is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med 2008, 14:437-441.
31. + T cells regulate surgical and postinfectious adhesion formation. J Exp Med 2002, 195:1471.
32. Holsti M., Chitnis T., Panzo R., Bronson R., Yagita H., Sayegh M., et al. Regulation of postsurgical fibrosis by the programmed death-1 inhibitory pathway. J Immunol 2004, 172:5774.
33. Ko ak I., ünlü C., Ak an Y., Yakin K. Reduction of adhesion formation with cross-linked hyaluronic acid after peritoneal surgery in rats. Fertil Steril 1999, 72:873-878.
34. Nagelschmidt M., Saad S. Influence of polyethylene glycol 4000 and dextran 70 on adhesion formation in rats. J Surg Res 1997, 67:113-118.
35. Wei C.Z., Hou C.L., Gu Q.S., Jiang L.X., Zhu B., Sheng A.L. A thermosensitive chitosan-based hydrogel barrier for post-operative adhesions' prevention. Biomaterials 2009, 30:5534-5540.
36. De Iaco P.A., Stefanetti M., Pressato D., Piana S., Dona M., Pavesio A., et al. A novel hyaluronan-based gel in laparoscopic adhesion prevention: preclinical evaluation in an animal model. Fertil Steril 1998, 69:318-323.
37. Diamond M.P. Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril 1998, 69:1067-1074.
38. Ustun C., Yanik F.F., Kocak I., Canbaz M.A., Cayli R. Effects of Ringer's lactate, medroxyprogesterone acetate, gonadotropin-releasing hormone analogue and its diluent on the prevention of postsurgical adhesion formation in rat models. Gynecol Obstet Invest 1998, 46:202-205.
39. Liakakos T., Thomakos N., Fine P.M., Dervenis C., Young R.L. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001, 18:260-273.
40. Attard J.A., MacLean A.R. Adhesive small bowel obstruction: epidemiology, biology and prevention. Can J Surg 2007, 50:291-300.
41. Burns J.W., Skinner K., Colt J., Sheidlin A., Bronson R., Yaacobi Y., et al. Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions. J Surg Res 1995, 59:644-652.
42. Rodgers K.E., Johns D.B., Girgis W., Campeau J., diZerega G.S. Reduction of adhesion formation with hyaluronic acid after peritoneal surgery in rabbits. Fertil Steril 1997, 67:553-558.
43. Reijnen M.M., Skrabut E.M., Postma V.A., Burns J.W., van Goor H. Polyanionic polysaccharides reduce intra-abdominal adhesion and abscess formation in a rat peritonitis model. J Surg Res 2001, 101:248-253.
44. Haney A.F., Doty E. Murine peritoneal injury and de novo adhesion formation caused by oxidized-regenerated cellulose (Interceed [TC7]) but not expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane). Fertil Steril 1992, 57:202-208.
45. Becker J.M., Dayton M.T., Fazio V.W., Beck D.E., Stryker S.J., Wexner S.D., et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 1996, 183:297-306.
46. Sawhney A.S., Pathak C.P., van Rensburg J.J., Dunn R.C., Hubbell J.A. Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention. J Biomed Mater Res 1994, 28:831-838.
47. Osada H., Takahashi K., Fujii T.K., Tsunoda I., Satoh K. The effect of cross-linked hyaluronate hydrogel on the reduction of post-surgical adhesion reformation in rabbits. J Int Med Res 1999, 27:233-241.
48. Liu Y., Li H., Shu X.Z., Gray S.D., Prestwich G.D. Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions. Fertil Steril 2005, 83:1275-1283.
49. Foley-Comer A.J., Herrick S.E., Al-Mishlab T., Prele C.M., Laurent G.J., Mutsaers S.E. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 2002, 115:1383-1389.